Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler.
about
Inhaled corticosteroids in children with persistent asthma: dose-response effects on growthBeclomethasone versus placebo for chronic asthmaLong-term safety of mometasone furoate/formoterol combination for treatment of patients with persistent asthmaAdd-on therapy options in asthma not adequately controlled by inhaled corticosteroids: a comprehensive reviewMometasone furoate nasal spray: a systematic reviewLong-term safety of mometasone furoate administered via a dry powder inhaler in children: Results of an open-label study comparing mometasone furoate with beclomethasone dipropionate in children with persistent asthma.Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study.Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary dThe efficacy and safety of mometasone furoate delivered via a dry powder inhaler for the treatment of asthma.Evidence-based selection of inhaled corticosteroid for treatment of chronic asthma.Mometasone furoate dry-powder inhaler for the control of persistent asthma.Inhaled mometasone furoate improves health-related quality of life in patients with persistent asthma.Mometasone furoate: an inhaled glucocorticoid for the management of asthma in adults and children.Inhaled corticosteroids in children with persistent asthma: dose-response effects on growth.Mometasone Furoate Suppresses PMA-Induced MUC-5AC and MUC-2 Production in Human Airway Epithelial CellsReduction in oral corticosteroid use with mometasone furoate dry powder inhaler improves health-related quality of life in patients with severe persistent asthma.Efficacy and safety of two dry-powder inhalers for the administration of mometasone furoate in asthma patients.Dose-dependent effects of inhaled mometasone furoate on airway function and inflammation after allergen inhalation challenge.Adrenal suppression with dry powder formulations of fluticasone propionate and mometasone furoate.Comparison of mometasone furoate dry powder inhaler and fluticasone propionate dry powder inhaler in patients with moderate to severe persistent asthma requiring high-dose inhaled corticosteroid therapy: findings from a noninferiority trial.Effects of mometasone furoate given once daily in the evening on lung function and symptom control in persistent asthma.Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo-controlled trial in children 4-9 years old with mild persistent asthma.An evaluation of the systemic bioavailability of mometasone furoate (MF) after oral inhalation from a MF/formoterol fumarate metered-dose inhaler versus an MF dry-powder inhaler in healthy subjects.
P2860
Q24194850-D64A1D34-E81D-485B-A54A-22412765D6B6Q24244887-1EBC79C7-26EA-4F7E-9EFC-C035958585C1Q24634033-F9DDB6F7-CD9F-4927-99AB-59A8A8C8E7D1Q24794527-4DAA2204-36DF-479E-AFBA-8CE2AFE0D9C4Q26747719-1B7D4194-9108-4B46-835C-95CE2138B511Q33481321-6EA06F28-77BF-4DD7-A08B-C172ED1ADEF5Q33522061-DF8C20F3-C088-4382-AD2B-FBDE4F5E8E98Q36679740-16C89FF3-C21C-4DAE-AC52-BB58FF668A7AQ36684524-D2899B23-B81B-4CD3-881B-A834B61BCA12Q36761823-0730F613-DE43-4CC2-BBB2-FB9B5AC16236Q36979360-B9D307BB-90BB-4D9B-93C7-EF77A317AD14Q37313138-434AE8AF-7E13-4EA5-85B0-8ADD94736C30Q37556510-C80E1209-193B-4915-82D2-13CCB30D19EFQ38287834-06E70A2B-98DC-4393-9868-AD2D22DDB833Q42275215-50668603-318E-4C6A-AD10-B1E373EDADA4Q42603944-13A1C5B1-5D30-412A-A399-7D1D4A94A6F0Q42909622-1C07EDFF-B9E2-45D5-8732-80EE03B655BCQ43718488-5CB4D90D-46D2-4FDC-9D8D-4EEF7DEB52E0Q44927006-D225353F-DB80-4C58-9F0B-724EEAD76CD4Q46642198-D9EC23B5-F42D-474F-8761-B8185C23FB78Q46786774-7920F0AC-D714-4549-9BDE-EE5603DDB5F6Q48943114-7B28627D-66AA-4EE5-B62F-2EEDC7982B46Q50247636-BA69A07C-E106-4B78-926B-D03DE561DE02
P2860
Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler.
@ast
Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler.
@en
Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler.
@nl
type
label
Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler.
@ast
Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler.
@en
Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler.
@nl
prefLabel
Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler.
@ast
Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler.
@en
Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler.
@nl
P2093
P1433
P1476
Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler.
@en
P2093
Berkowitz RB
Bernstein DI
Chervinsky P
Harrison JE
Karetzky M
P304
P356
10.1016/S0954-6111(99)90099-9
P577
1999-09-01T00:00:00Z